Adverse Reactions to Pneumococcal Vaccine in Pediatric and Adolescent Patients with Sickle Cell Disease

E-ISSN： 1875-9114|35|7|696-700

ISSN： 0277-0008

Source： PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol.35, Iss.7, 2015-07, pp. : 696-700

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

13‐valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6‐17 years of age with sickle cell disease previously vaccinated with 23‐valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 8, 2015-08 ,pp. : 1427-1436

John Wiley & Sons Inc

Access to resources Recommend Favorite

How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 6, 2015-09 ,pp. : 745-756

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hypogonadism in Patients with Sickle Cell Disease: Central or Peripheral?

Acta Haematologica, Vol. 128, Iss. 2, 2012-06 ,pp. : 65-68

Karger

Access to resources Recommend Favorite

Improvement in influenza vaccination rates in a pediatric sickle cell disease clinic

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 4, 2015-04 ,pp. : 654-657

John Wiley & Sons Inc

Access to resources Recommend Favorite

Variation in Pediatric Emergency Department Care of Sickle Cell Disease and Fever

ACADEMIC EMERGENCY MEDICINE, Vol. 22, Iss. 4, 2015-04 ,pp. : 423-430

John Wiley & Sons Inc

Access to resources Recommend Favorite